How to Buy Ascendis Pharma A Stock
Ascendis Pharma A
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments.
Ascendis Pharma A stock last closed at $263.52, up 0.87% from the previous day, and has increased 33.31% in one year. It has overperformed other stocks in the Biotechnology industry by 0.47 percentage points. Ascendis Pharma A stock is currently +41.63% from its 52-week low of $186.05, and -6.6% from its 52-week high of $282.15.
There are currently 65.67M shares of ASND outstanding. The market value of ASND is $17.31B. In the last 24 hours, 435,000 ASND shares were traded.
How to Buy Ascendis Pharma A Stock
Not sure how to invest in Ascendis Pharma A stock? Here's how.
- Figure out where to buy Ascendis Pharma A stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Ascendis Pharma A stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Choose your method of payment and add your information.
- Research Ascendis Pharma A stock: The Ascendis Pharma A ticker symbol is ASND. Is Ascendis Pharma A stock a good investment? Should you buy shares of ASND? How do ASND's underlying business fundamentals look? Do top analysts think Ascendis Pharma A is a good buy? Why has ASND's stock price moved recently? (Hint: Our stock market research website can help you understand if ASND is a good stock to buy).
- Make your ASND trade: Decide if you will purchase ASND shares at the current market price or use a limit order to purchase ASND shares at a given price.
- Get updates on your investment in ASND: Create a watchlist to keep track of your investment in Ascendis Pharma A shares.
Step 1: Figure out where to buy Ascendis Pharma A stock
You will need a brokerage account in order to access the NASDAQ market and buy ASND stock.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal info so you can buy ASND today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've filled out your info on stock market apps, you need to deposit funds:
Check out the tutorial below for more details transferring money into your new brokerage account.
Step 4: Research Ascendis Pharma A stock
After you have selected the best place to buy Ascendis Pharma A stock, it's crucial to research their stock prior to buying, so you truly comprehend the risk as well as the upside.
Ascendis Pharma A shares quick numbers
ASND Due Diligence Checks
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ASND's stock page.
Is ASND stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ASND's true value.
Using relative valuations methods:
- ASND could be overvalued based on its P/E ratio of 19.23x, relative to Biotechnology industry P/E ratio of 8.81x
- ASND may be overvalued based on its P/B ratio of 10.45x, relative to Biotechnology industry P/B ratio of 5.32x
You can access additional valuation research on ASND's stock here.
ASND Financial Overview
Passed Financial Due Diligence Checks:
- ASND profit margin has gone up from -55.3% to 70.8% in the past year.
- ASND's operating cash flow of $403.13M allows it to safely service it's debt of $519.12M.
- There are more short-term assets than short-term liabilities on the ASND balance sheet.
- There are more short-term assets than long-term liabilities on the ASND balance sheet.
Failed Financial Due Diligence Checks:
- ASND has a relatively high debt to equity ratio of 0.59.
- Total ASND debt is higher than 5 years ago, relative to shareholder equity.
- ASND earnings of $355.42M is not enough to cover its interest payments.
Is it a good time to buy ASND stock, according to analysts?
Out of 14 Wall Street analysts who research ASND, the consensus analyst rating on Ascendis Pharma A is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Latest ASND Analyst Forecasts
Alex Thompson, a top 9% analyst from Stifel Nicolaus maintains ASND with a strong buy rating and lowers their ASND price target from $328.00 to $326.00, on Aug 31, 2026.
Mitchell S. Kapoor, a top 12% analyst from HC Wainwright & Co. maintains ASND with a buy rating and lowers their ASND price target from $345.00 to $344.00, on Aug 31, 2026.
David Lebovitz, a top 11% analyst from BMO Capital initiates coverage on ASND with a buy rating and announces their ASND price target of $319.00, on Aug 19, 2026.
Yaron Werber, a top 23% analyst from TD Cowen maintains ASND with a strong buy rating and raises their ASND price target from $325.00 to $341.00, on Aug 14, 2026.
TD Cowen's Yaron Werber raised their price target on Ascendis Pharma A (NASDAQ: ASND) by 4.9% from $325 to $341 on 2026/08/14. The analyst maintained their Strong Buy rating on the stock.
Ascendis Pharma reported its Q2 2026 earnings.
Raising their price target, Werber referenced the quarter's "solid" results.
Earnings Report
For Q2 2026, Ascendis Pharma reported:
- EPS of €0.90, up from Q2 2025's €0.07.
- Revenue of €339.3M, up from Q2 2025's €158M.
Management did not provide financial guidance in its press release.
President & CEO Jan Mikkelsen commented: “Our patient focus has driven achievement of important milestones and strong demand for our TransCon products as Ascendis continues to transform into a leading biopharma company.
“This focus on addressing unmet medical needs continues to drive a growing pipeline of innovative TransCon programs, further positioning Ascendis for durable, long-term growth in rare endocrine diseases and new therapeutic areas.”
Luca Issi, a top 10% analyst from RBC Capital maintains ASND with a buy rating and raises their ASND price target from $280.00 to $290.00, on Aug 14, 2026.
You can dive deeper into what analysts are saying on the Ascendis Pharma A stock forecast page.
ASND Momentum
Is ASND Making Money?
Last year, ASND revenue was $1.21B. During the last five year, ASND's revenue has gone up by 187.82% per year. This was faster than the Biotechnology industry average of 23.88%.
You can analyze ASND's earnings and revenue performance here.
Who is buying/selling ASND?
In the past 12 months, insiders at ASND have sold more shares than they have bought.
Mads Bodenhoff, PAO;SVP of ASND, was the latest ASND insider to buy. They bought $330,000.00 worth of ASND shares on Sep 8, 2026.
Get more info about who owns ASND stock here.
Can I get consistent income from ASND stock?
No, Ascendis Pharma A doesn't provide an income stream by paying out dividends.
What do other traders have to say about ASND?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your ASND trade
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount limit, use a limit order.
Click the Open button and eToro will execute the order.
If you want more help with buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your investment in ASND
Now that you own some ASND shares, you'll want to keep up with your investment.
Make a watchlist to monitor your ASND stock.
ASND Feed
How to Buy Stock in Ascendis Pharma A
To reiterate, here are the 6 steps to buy Ascendis Pharma A stock:
- Figure out where to buy Ascendis Pharma A stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Research Ascendis Pharma A stock
- Make your ASND trade
- Get updates on your investment in ASND
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Ascendis Pharma A, click below.
Other Content You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.